Dr. Junchao Tong is a staff scientist with the Brain Health Imaging Centre at the Centre (BHIC) for Addiction and Mental Health (CAMH). He received his BS in biochemistry from Tsinghua University and PhD in molecular biology from the Institute of Biophysics, Chinese Academy of Sciences in Beijing, P. R. China. Afterwards he obtained his postdoctoral training on mitochondrial protein translocation with Dr. Emanuel Margoliash at the University of Illinois at Chicago and then Toronto with Dr. Stephen Kish at CAMH, working on autopsied human brains and human brain imaging in drugs of abuse (methamphetamine, cocaine, heroin, alcohol and cannabis) and movement disorders including Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. Dr. Tong was recruited as the head of Preclinical Imaging at BHIC CAMH in 2016.
Areas of Research
Dr. Tong’s research interests include positron emission tomography magnetic resonance (PET-MR) and computed tomography (PET-CT) imaging of rodent models of a variety of human conditions such as Alzheimer’s disease, Parkinson’s disease, brain trauma, epilepsy, major depression, schizophrenia, etc. In addition, Dr. Tong's interests include new PET radiopharmaceutical development targeting different brain receptors, transporters, enzymes and proteins, and also PET imaging methodology for quantitative imaging outcome measures in rodents.
Publications
View Dr. Tong’s publications on myNCBI.